To quantify serum levels of interleukin-11 (IL-11) and matrix metalloproteinase-9 (MMP-9) in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and to investigate the role of mast cells, particularly in relation to stimulation by Epstein-Barr Virus (EBV).
Key Findings:
Significant increase in serum levels of IL-11 and MMP-9 in ME/CFS patients compared to healthy controls, indicating potential biomarkers.
Mast cells stimulated by recombinant EBV protein released higher amounts of MMP-9 compared to control cells, suggesting a mechanism of action.
Interpretation:
IL-11, MMP-9, and mast cells may play a role in the pathology of ME/CFS.
Limitations:
Study limited to female patients, which may affect generalizability to the broader ME/CFS population.
Small sample size for MMP-9 analysis limits the robustness of the findings.
Conclusion:
The findings suggest a potential involvement of IL-11 and MMP-9 in ME/CFS pathology, warranting further investigation into their roles as biomarkers and therapeutic targets.
by Baskaran Chinnappan, Duraisamy Kempuraj, Kristina K. Aenlle, Ashley Middleton, Katie S. Day, Sai Puneeth Kothuru, Rhitik Samir Joshi, Nancy G. Klimas, Theoharis C. Theoharides
